Viewing nowCombinationTeldipin Tablets 40/5 mg (Telmisartan, Amlodipine Besylate)
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
TK Pharmaceutical Co., Ltd.

MFDS item code 201901435 · Approved 2019.03.08 · Insurance code 644805580
Treatment of essential hypertension not controlled with monotherapy
Used to effectively manage blood pressure in cases where blood pressure is not sufficiently controlled by monotherapy with Telmisartan or Amlodipine.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine; however, switching directly to this medicine may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients requiring careful administration'). In patients aged 75 years and older, amlodipine clearance is decreased; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, use of this medicine is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Do not use in persons allergic to any components included in this medication or similar substances, in pregnant or potentially pregnant women, in nursing women, in patients with severe liver or heart problems, in patients with hypotension or in shock, etc. Caution should be taken when administering this medication to patients with poor liver function or biliary obstruction, as its metabolism may be slowed down. Patients with gastrointestinal diseases should use this medication with caution, as gastrointestinal bleeding and other complications may occur during treatment. Patients with kidney issues or abnormalities in renal blood vessels may experience hypotension or worsening kidney function, necessitating regular monitoring. Elderly patients may exhibit stronger effects from this medication, thus dosage adjustments should be handled carefully. This medication lowers blood pressure; therefore, when starting treatment or changing dosage, care should be taken for symptoms of hypotension, and dizziness or drowsiness may occur, requiring caution when driving or operating machinery. Potassium levels may increase while taking this medication, so regular monitoring of serum potassium levels is necessary when used in conjunction with potassium-containing medications or supplements. Patients with heart disease need to be careful, as there may be an increased risk of angina or myocardial infarction following administration of this medication. There may be interactions with other medications, especially when taken with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs (NSAIDs), simvastatin, tacrolimus, etc.; consult your doctor or pharmacist in such cases. Overdose may result in symptoms such as hypotension, dizziness, arrhythmia, and renal failure, necessitating an immediate visit to a healthcare facility, where treatment should be based on symptoms. The safety and efficacy of this medication in children have not been fully established; therefore, it is advisable not to use it in this population.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light and should be stored in a tightly sealed container that blocks light. It is advisable to maintain storage temperatures between 1 and 30 degrees Celsius to preserve the medication's efficacy and safety.
Biconvex dual-coated oval tablets in white and light blue colors
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
TK Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.